Vasily N. Dobrovolsky received MS degree in Biotechnology from Moscow Institute of Physics and Technology (Moscow, Russia) and PhD degree in Molecular Biology from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCh RAS). In 1998, Dr. Dobrovolsky has joined the US Food and Drug Administration as a staff fellow at the National Center for Toxicological Research (Jefferson, Arkansas). Currently as a Senior Scientist, he oversees a group consisting of postdoctoral students, support personnel and staff scientists who are involved in research projects in the field of basic and applied genetic toxicology. His group is using advanced flow cytometry, fluorescence microscopy and next generation sequencing for designing and validating methodologies used for safety assessment of FDA-regulated products. Over the years Dr. Dobrovolsky published over 70 research and scholar articles in peer-reviewed journals and books on detecting in vitro and in vivo mutation, using transgenic and knockout animals in biotechnology and mutation research, characterizing spectra of mutations with high throughput methods. Dr. Dobrovolsky is a member of an influential Genetic Toxicology Technical Committee of the Washington, DC, based Health and Environmental Sciences Institute that advances genetic toxicology and human risk assessment through the international collaboration of experts from industry, government and academia.